EXSYS DEXi (EXSYS DEXi-S40S); EXSYS DEXi (EXSYS DEXi-S40P); EXSYS DEXi (EXSYS DEXi-S40T); EXSYS DEXi (EXSYS DEXi-S50H
DRTECH Corporation · Decision date Sep 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-08 for K260227, a traditional 510(k) submitted by DRTECH Corporation of Seongnam-Si, KR, and received on 01/26/2026. The listed device is EXSYS DEXi, with model designations EXSYS DEXi-S40S, EXSYS DEXi-S40P, EXSYS DEXi-S40T and EXSYS DEXi-S50H. The classification name is System, X-Ray, Stationary, under regulation 892.1680, product code KPR, in the Radiology specialty and review panel. SESE means clearance to market, not PMA approval.
The record shows no third-party review, no combination product status and no authorized Predetermined Change Control Plan. The page does not state which components or modifications were assessed, what predicates were cited, or what testing supported the decision; those details would sit in the underlying 510(k) review documents rather than this summary page. No clinical performance, dosing or labeling conclusions are drawn here.
Hanbyul Kim is listed as both applicant contact and correspondent contact. The page was last updated 09/14/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260227
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- DRTECH Corporation
- Product code
- KPR
- Decision code
- SESE
- Decision date
- Sep 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, X-Ray, Stationary.
- Applicant
- DRTECH Corporation
- Product code
- KPR
- FDA device class
- 2
FDA decision timeline
K260227 received
Application receipt date recorded by FDA.
K260227 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
DRTECH Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Seongnam-Si
Sources and methodology
- Original FDA record: K260227
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records